Medical News

RSS

Oculus Innovative Sciences Receives Medicare HCPCS Code For Reimbursement Of Microcyn® Skin & Wound Hydrogel

Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, announced today that Noridian Administrative Services LLC, which is the pricing, data analysis and coding contractor for the Medicare program with respect to durable medical equipment, prosthetics, orthotics, and medical supplies, has assigned a Medicare HCPCS code for Oculus’ recently introduced Microcyn Skin & Wound HydroGel.

11 Sep 2009

President Obama's proposed changes are not what an already-indebted country needs: BestHealthcareRates.com

The team from BestHealthcareRates.com is less than reassured with the presidential reassurances on the far-reaching effects of health care reform during his September 9th talk on the status of healthcare reform. With more than 46.3 million Americans not having medical insurance the need for changes is long overdue, but many of those proposed by Obama are not what an already-indebted country needs.

11 Sep 2009

Care Support of America on overlooked healthcare issues in eldercare and family caregiving

As healthcare reform is being debated in Congress and on Main Street, vital and practical issues in eldercare and family caregiving are being overlooked. Some 30 million U.S. baby boomers are family caregivers for their aging parents, trying to keep their parents safe at home and helping them navigate the complexities of Medicare and manage an advancing illness. If they had their say, most elderly people would prefer to age in their own homes.

11 Sep 2009

YuYeQingHuo OTC capsules to treat throat inflammation launched by American Oriental Bioengineering

American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that the Company has launched a new product called YuYeQingHuo Capsules ("YYQH").

11 Sep 2009

Bed bugs are back in America

They're BAA-AACK! Thirty years after bed bugs were believed to be exterminated nationwide, the teeny, insidious bloodsuckers--which feast on sleeping humans--are making a comeback of epidemic proportions.

11 Sep 2009

Accupac to manufacture Access Pharmaceuticals' MuGard

ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) has entered into an agreement with a leading commercial manufacturer to produce its FDA-approved MuGard for North American distribution. One or more U.S. market seeding studies could begin as early as Q4 2009, the company says.

11 Sep 2009

Health policy research roundup

Robert Wood Johnson Foundation: A Snapshot of U.S. Physicians: Key Findings from the 2008 Health Tracking Physician Survey - This brief reviews findings from the Center for Studying Health System Change (HSC) 2008 Health Tracking Physician Survey, a national survey including the responses of more than 4,700 U.S. physicians who provide "at least 20 hours per week of direct patient care."

11 Sep 2009

2nd West Coast Forum: An opportunity to gather the latest information on clinical supply chain management

The Center for Business Intelligence (CBI) is pleased to announce the full agenda for their 2nd West Coast Forum on Clinical Supply Chain Management. The conference takes place in Burlingame, CA, on October 28-29, 2009.

11 Sep 2009

Number of uninsured grows even as government programs cover more Americans

Kaiser Health News reports: "More children had health insurance last year, partially offsetting a growing number of adults who lacked coverage as the troubled economy helped push insurance out of reach for many workers. New Census Bureau numbers show the total number of uninsured rose to 46.3 million in 2008, up from 45.6 million in 2007. The percentage of uninsured remained at 15.4 percent."

11 Sep 2009

University of Surrey lecturer on Co-sleeping

The event will be a series of overlapping presentations based on video clips of older people talking about their experience of poor sleep, and the impact this has on their lives. The presenters are all involved in the SomnIA (Sleep in Ageing) project based at the University of Surrey. As well as the video-based presentations and discussions, members of the audience will be invited to share some of their own experiences of poor sleep, and write down questions which they would like the panel of presenters to address during the last part of the event.

11 Sep 2009

Restated 2008 and 2009 financial results released by The Center for Wound Healing

The Center for Wound Healing, Inc. (OTCBB:CFWH), a leading operator of comprehensive wound care treatment centers that offer hyperbaric oxygen therapy as well as other advanced wound care treatment modalities, today announced that the Company’s consolidated financial statements for the quarter ended March 31, 2008 and for the year ended June 30, 2008 need to be restated as described below, and that investors should no longer rely upon those consolidated financial statements. The Company will file an amendment to the 2008 Form 10-QSB and 2008 Form 10-KSB to restate the 2008 Financial Statements as soon as practicable.

11 Sep 2009

The NY Chiropractic Council, PCA, and ANJC sue the Blue Cross Blue Shield Association

The NY Chiropractic Council (the "Council") as well as the Pennsylvania Chiropractic Association ("PCA"), the Association of New Jersey Chiropractors ("ANJC"), fourteen individual chiropractors and one occupational therapist, located around the country, have sued as the class representatives of the putative class.

11 Sep 2009

Immigration and education policies to impact United states' leadership in science and discovery

Immigration and education policy experts gathered on Capitol Hill today to address the impact of policies related to U.S. medical innovation. The briefing, titled Education & Immigration: The Building Blocks of Innovation, was sponsored by the Council for American Medical Innovation as the first in a three-part series, Recovery Through Discovery, which examines medical innovation as a driver of U.S. economic recovery and enhanced global leadership in science.

11 Sep 2009

Mayo study raises hope for treating multiple sclerosis

A Mayo Clinic study has found that two genes in mice were associated with good central nervous system repair in multiple sclerosis (MS). These findings give researchers new hope for developing more effective therapies for patients with MS and for predicting MS patients' outcomes. This study will be presented at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, Germany, on Sept. 11, 2009.

11 Sep 2009

Texas Scottish Rite Hospital for Children to benefit from marathon event

The Dallas White Rock Marathon today announced that MetroPCS Communications, Inc., the nation's leading provider of unlimited, flat-rate, no signed contract wireless communications service, will be the title sponsor of this year’s marathon. The event will now be called the MetroPCS Dallas White Rock Marathon presented by NexBank.

11 Sep 2009

Abell Foundation plays major role in BioMarker's $1.7M private placement funding

BioMarker Strategies announced today that it has raised $1.7 million in a private placement funding round that occurred in conjunction with the Maryland Biotechnology Investment Incentive Tax Credit Program. BioMarker Strategies is developing the patent-pending, SnapPath™ testing system to enable oncologists to determine the most effective drug treatment for their cancer patients.

11 Sep 2009

Public Campaign Action Fund raises conflict of interest questions about Rep. Charles Boustany

Public Campaign Action Fund raised serious conflict of interest questions about Rep. Charles Boustany (R-La.) and the expected opposing remarks he will deliver tonight in response to President Barack Obama's speech to a joint session of Congress on health care reform.

11 Sep 2009

Genspera to commence G-202 Phase I trial following FDA approval

GenSpera, Inc. announced today that the Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to begin a Phase I study with its target activated pro-drug, G-202, for the treatment of cancer.

11 Sep 2009

IMIA Salary Survey to provide key insight into the medical interpreting profession

A new 2009 IMIA Salary Survey will offer key insight into the medical interpreting profession. The strongest participation ever is anticipated, based on trends in this fast-emerging profession.

11 Sep 2009

Health Management Associates signs a five-year medical transcription services contract with Transcend

TRANSCEND SERVICES, INC. (NASDAQ: TRCR), the third largest provider of medical transcription services to the U.S. healthcare market, announced today that it has entered into a five-year single-source contract to provide medical transcription services to Health Management Associates, Inc. (NYSE: HMA) (“HMA”).

11 Sep 2009

Medical News

Oculus Innovative Sciences Receives Medicare HCPCS Code For Reimbursement Of Microcyn® Skin & Wound Hydrogel

President Obama's proposed changes are not what an already-indebted country needs: BestHealthcareRates.com

Care Support of America on overlooked healthcare issues in eldercare and family caregiving

YuYeQingHuo OTC capsules to treat throat inflammation launched by American Oriental Bioengineering

Bed bugs are back in America

Accupac to manufacture Access Pharmaceuticals' MuGard

Health policy research roundup

2nd West Coast Forum: An opportunity to gather the latest information on clinical supply chain management

Number of uninsured grows even as government programs cover more Americans

University of Surrey lecturer on Co-sleeping

Restated 2008 and 2009 financial results released by The Center for Wound Healing

The NY Chiropractic Council, PCA, and ANJC sue the Blue Cross Blue Shield Association

Immigration and education policies to impact United states' leadership in science and discovery

Mayo study raises hope for treating multiple sclerosis

Texas Scottish Rite Hospital for Children to benefit from marathon event

Abell Foundation plays major role in BioMarker's $1.7M private placement funding

Public Campaign Action Fund raises conflict of interest questions about Rep. Charles Boustany

Genspera to commence G-202 Phase I trial following FDA approval

IMIA Salary Survey to provide key insight into the medical interpreting profession

Health Management Associates signs a five-year medical transcription services contract with Transcend

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Latest News